FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2602850349> ?p ?o ?g. }

• W2602850349 abstract "Background Optimisation of treatment for patients with renal insufficiency (RI) is necessary to avoid excessive or insufficient dosing of drugs. Identification and selection of adequate treatments for RI patients is mainly limited by time. Purpose To assess data obtained data for the first 2 months after a new semi-automatic validation tool for physicians’ prescriptions of treatments for RI patients. Material and methods A descriptive prospective study of pharmaceutical interventions was conducted. Medications prescribed to RI patients during the first 2 months after implementation of the new software (1 August 2016 to 01 October 2016) were evaluated. Farmatools application from computerised physician order entry system (CPOE) was used to obtain treatments of all kidney failure patients. Inpatients’ serum creatinine values were checked from clinical analysis laboratory based on real time blood test. Clearance of creatinine (ClCr) urine values were achieved for equation MDRD-4 (IDMS). Both databases were integrated and associated with Access using ODBC. It identifies RI patients with at least 2 stable values of ClCr 2 . Every day, a report on prescribed treatment for RI patients was automatically generated and a suitable treatment was proposed automatically by the new software for each patient. The pharmacist validated the generated reports each day and informed the physicians about differences detected between the original prescriptions and the semi-automatic recommendations tool, using CPOE. The number of pharmaceutical interventions carried out, medical departments and drugs involved were analysed. Results There were 2076 inpatients during the study period. Medication prescriptions and RI were checked every day during hospitalisation for all of them. New software allowed the pharmacist to check all CLCr values and prescribed treatments of each inpatient in less than 10 min a day. A total of 33 pharmacist recommendations in 32 inpatients were recorded. internal medicine (63.6%), cardiology (12.1%) and neurology (9%) were departments with more pharmaceutical suggestions. Drugs most frequently involved were: ranitidine (27.8%), ramipril (12.1%), morphine (9.1%), enalapril (6.1%), levofloxacin (6.1%), enoxaparin (6.1%), allopurinol (6.1%), simvastatin (6.1%) and spironolactone (6.1%). Conclusion The new semi-automatic validation tool allowed time optimisation: the assessing team of RI patients was able to check all treatments of inpatients quickly each day. More than 25% of pharmacist interventions involved ranitidine. The most frequent discrepancies detected were carried out in internal medicine and cardiology inpatients. No conflict of interest" @default.
• W2602850349 created "2017-04-07" @default.
• W2602850349 creator A5001060506 @default.
• W2602850349 creator A5025099615 @default.
• W2602850349 creator A5026941208 @default.
• W2602850349 creator A5027330587 @default.
• W2602850349 creator A5039960113 @default.
• W2602850349 creator A5044999182 @default.
• W2602850349 creator A5071750906 @default.
• W2602850349 creator A5074037141 @default.
• W2602850349 creator A5077788052 @default.
• W2602850349 creator A5091332979 @default.
• W2602850349 date "2017-02-25" @default.
• W2602850349 modified "2023-09-27" @default.
• W2602850349 title "PS-071 A new semi-automatic tool for assessing treatment prescribing based on real time blood tests" @default.
• W2602850349 doi "https://doi.org/10.1136/ejhpharm-2017-000640.577" @default.
• W2602850349 hasPublicationYear "2017" @default.
• W2602850349 type Work @default.
• W2602850349 sameAs 2602850349 @default.
• W2602850349 citedByCount "0" @default.
• W2602850349 crossrefType "proceedings-article" @default.
• W2602850349 hasAuthorship W2602850349A5001060506 @default.
• W2602850349 hasAuthorship W2602850349A5025099615 @default.
• W2602850349 hasAuthorship W2602850349A5026941208 @default.
• W2602850349 hasAuthorship W2602850349A5027330587 @default.
• W2602850349 hasAuthorship W2602850349A5039960113 @default.
• W2602850349 hasAuthorship W2602850349A5044999182 @default.
• W2602850349 hasAuthorship W2602850349A5071750906 @default.
• W2602850349 hasAuthorship W2602850349A5074037141 @default.
• W2602850349 hasAuthorship W2602850349A5077788052 @default.
• W2602850349 hasAuthorship W2602850349A5091332979 @default.
• W2602850349 hasConcept C10446079 @default.
• W2602850349 hasConcept C104863432 @default.
• W2602850349 hasConcept C126322002 @default.
• W2602850349 hasConcept C159110408 @default.
• W2602850349 hasConcept C159641895 @default.
• W2602850349 hasConcept C177713679 @default.
• W2602850349 hasConcept C194828623 @default.
• W2602850349 hasConcept C2426938 @default.
• W2602850349 hasConcept C27415008 @default.
• W2602850349 hasConcept C2777288759 @default.
• W2602850349 hasConcept C2779457091 @default.
• W2602850349 hasConcept C2780306776 @default.
• W2602850349 hasConcept C512399662 @default.
• W2602850349 hasConcept C71924100 @default.
• W2602850349 hasConcept C98274493 @default.
• W2602850349 hasConceptScore W2602850349C10446079 @default.
• W2602850349 hasConceptScore W2602850349C104863432 @default.
• W2602850349 hasConceptScore W2602850349C126322002 @default.
• W2602850349 hasConceptScore W2602850349C159110408 @default.
• W2602850349 hasConceptScore W2602850349C159641895 @default.
• W2602850349 hasConceptScore W2602850349C177713679 @default.
• W2602850349 hasConceptScore W2602850349C194828623 @default.
• W2602850349 hasConceptScore W2602850349C2426938 @default.
• W2602850349 hasConceptScore W2602850349C27415008 @default.
• W2602850349 hasConceptScore W2602850349C2777288759 @default.
• W2602850349 hasConceptScore W2602850349C2779457091 @default.
• W2602850349 hasConceptScore W2602850349C2780306776 @default.
• W2602850349 hasConceptScore W2602850349C512399662 @default.
• W2602850349 hasConceptScore W2602850349C71924100 @default.
• W2602850349 hasConceptScore W2602850349C98274493 @default.
• W2602850349 hasLocation W26028503491 @default.
• W2602850349 hasOpenAccess W2602850349 @default.
• W2602850349 hasPrimaryLocation W26028503491 @default.
• W2602850349 hasRelatedWork W2073891019 @default.
• W2602850349 hasRelatedWork W2096271456 @default.
• W2602850349 hasRelatedWork W2187276633 @default.
• W2602850349 hasRelatedWork W2234424992 @default.
• W2602850349 hasRelatedWork W2284458649 @default.
• W2602850349 hasRelatedWork W2342236123 @default.
• W2602850349 hasRelatedWork W2361988220 @default.
• W2602850349 hasRelatedWork W2411295237 @default.
• W2602850349 hasRelatedWork W2413503474 @default.
• W2602850349 hasRelatedWork W2414523561 @default.
• W2602850349 hasRelatedWork W2502304307 @default.
• W2602850349 hasRelatedWork W2573663618 @default.
• W2602850349 hasRelatedWork W2619215016 @default.
• W2602850349 hasRelatedWork W2687361822 @default.
• W2602850349 hasRelatedWork W2802351040 @default.
• W2602850349 hasRelatedWork W2805310625 @default.
• W2602850349 hasRelatedWork W2904515808 @default.
• W2602850349 hasRelatedWork W2969244869 @default.
• W2602850349 hasRelatedWork W3033779575 @default.
• W2602850349 hasRelatedWork W3132342674 @default.
• W2602850349 isParatext "false" @default.
• W2602850349 isRetracted "false" @default.
• W2602850349 magId "2602850349" @default.
• W2602850349 workType "article" @default.